Difficulty: Medium
Average Score: 72%
Practice
In ulcerative colitis:
Correct answer
A
Rationale
In ulcerative colitis, the correct answer is option A) Intravenous hydrocortisone is of proven value in the treatment of acute colitis. This is because intravenous corticosteroids, such as hydrocortisone, are the mainstay of treatment for acute exacerbations of ulcerative colitis due to their potent anti-inflammatory effects. They help reduce inflammation and symptoms quickly in severe cases.
Option B) Oral corticosteroids are not typically first-line for maintenance treatment in ulcerative colitis. Maintenance treatment often involves other medications like immunomodulators or biologics to prevent flare-ups and maintain remission.
Option C) Localized rectal disease in ulcerative colitis often responds well to topical treatments like mesalamine enemas or suppositories rather than systemic corticosteroids like prednisolone.
Option D) In severe colitis, codeine should never be used as it can worsen symptoms and lead to complications like toxic megacolon. Codeine is not recommended in inflammatory bowel disease due to its potential to slow down the gastrointestinal tract and exacerbate inflammation.
Educationally, it is crucial for healthcare providers to understand the appropriate treatment options for ulcerative colitis to ensure optimal patient outcomes. Knowing which medications are effective in different scenarios helps in providing timely and effective care to patients with this chronic condition, thereby improving their quality of life.
Option B) Oral corticosteroids are not typically first-line for maintenance treatment in ulcerative colitis. Maintenance treatment often involves other medications like immunomodulators or biologics to prevent flare-ups and maintain remission.
Option C) Localized rectal disease in ulcerative colitis often responds well to topical treatments like mesalamine enemas or suppositories rather than systemic corticosteroids like prednisolone.
Option D) In severe colitis, codeine should never be used as it can worsen symptoms and lead to complications like toxic megacolon. Codeine is not recommended in inflammatory bowel disease due to its potential to slow down the gastrointestinal tract and exacerbate inflammation.
Educationally, it is crucial for healthcare providers to understand the appropriate treatment options for ulcerative colitis to ensure optimal patient outcomes. Knowing which medications are effective in different scenarios helps in providing timely and effective care to patients with this chronic condition, thereby improving their quality of life.